Home Cart 0 Sign in  

[ CAS No. 89856-44-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 89856-44-0
Chemical Structure| 89856-44-0
Structure of 89856-44-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 89856-44-0 ]

Related Doc. of [ 89856-44-0 ]

Alternatived Products of [ 89856-44-0 ]

Product Details of [ 89856-44-0 ]

CAS No. :89856-44-0 MDL No. :MFCD00151793
Formula : C7H9BrN2 Boiling Point : -
Linear Structure Formula :- InChI Key :BFRMYMFNSHASRJ-UHFFFAOYSA-N
M.W : 201.06 Pubchem ID :11030855
Synonyms :

Calculated chemistry of [ 89856-44-0 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.29
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 1.0
Molar Refractivity : 46.27
TPSA : 38.91 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.13 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.91
Log Po/w (XLOGP3) : 1.96
Log Po/w (WLOGP) : 2.05
Log Po/w (MLOGP) : 1.65
Log Po/w (SILICOS-IT) : 2.2
Consensus Log Po/w : 1.96

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.77
Solubility : 0.345 mg/ml ; 0.00172 mol/l
Class : Soluble
Log S (Ali) : -2.4
Solubility : 0.796 mg/ml ; 0.00396 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.3
Solubility : 0.101 mg/ml ; 0.000504 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.71

Safety of [ 89856-44-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 89856-44-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 89856-44-0 ]
  • Downstream synthetic route of [ 89856-44-0 ]

[ 89856-44-0 ] Synthesis Path-Upstream   1~9

  • 1
  • [ 5407-87-4 ]
  • [ 89856-44-0 ]
YieldReaction ConditionsOperation in experiment
84% With N-Bromosuccinimide In acetonitrile at 20℃; for 5 h; Inert atmosphere Example 2: preparation of 2-N,N-dimethylamino-5-hydroxy-4-methyl-6-(10- x decyl)-pyridine; 2-Amino-5-bromo-4,6-dimethylpyridine (13):To a stirred solution containing 2.00g (16.32 mmol) of 2-amino-4,6-dimethylpyridine in 25 mL of acetonitrile were added 2.90g (16.32 mmol) of N-bromosuccinimide. The reaction mixture was stirred at room temperature under argon atmosphere for 5 h. The formed precipitate was filtered and dried to afford the expected product as a white solid: yield 2.76g (84percent). 1H-NMR(CDC13) δ 6.22 (s, 1H), 4.39 (br, 2H), 2.48 (s, 3H), 2.25 (s, 3H);13C-NMR (CDC13) 5156.34, 155.23, 148.64, 112.26, 108.10, 25.10, 23.30.
84% With N-Bromosuccinimide In acetonitrile at 20℃; for 5 h; Inert atmosphere To a stirred solution containing 2.00 g (16.3 mmol) of 2-amino-4,6-dimethylpyridine in 25 mL of acetonitrile was added 2.90 g (16.3 mmol) of N-bromosuccinimide. The reaction mixture was stirred at room temperature for 5 h. The formed precipitate was filtered and dried to afford 6-amino-3-bromo-2,4-dimethylpyridine (8) as a colorless solid: yield 2.76 g (84percent); mp 143–145 °C; silica gel TLC Rf 0.15 (2:1 hexanes/ethyl acetate); 1H NMR (CDCl3) δ 2.25 (s, 3H), 2.48 (s, 3H), 4.39 (br s, 2H), and 6.22 (s, 1H); 13C NMR (CDCl3) δ 23.3, 25.1, 108.1, 112.3, 148.6, 155.2, and 156.3; mass spectrum (APCI), m/z 201.0032 (M+H)+ (C7H10N2Br requires 201.0027).
77% With bromine In acetonitrile at 20℃; for 1 h; A mixture of 4,6-dimethylpyridin-2-amine (3 g) and Bromine (1 .39 mL) taken up in Acetonitrile (30 mL) was stirred at ambient temperature for I h. The mixture was diluted with Water (100 mL) and the precipitate was collected by filteration and dried to afford the title product as a off white solid (3.8 g, 77percent). LCMS: Rt: 1.2 min; MS: mz = 203 (M+1) 1H NMR (300 MHz, Chloroform-d) 67.28 (5, IH), 6.37 (5, 2H), 2.43-2.12 (m, 6H).
76% With dihydrogen peroxide; 1-butylpyridinium bromide; toluene-4-sulfonic acid In 1,2-dimethoxyethane at 80℃; for 24 h; Schlenk technique; Inert atmosphere; Green chemistry General procedure: To a mixture of 2-aminopyridine (0.5 mmol, 1 equiv), p-TSA (0.4 mmol,0.8 equiv), 1-butylpyridinium bromide (1.5 mmol, 3 equiv) in a 50 mL Schlenk tube were added 1,2-dimethoxyethane (2 mL) under air. Then H2O2 (1.2 mmol, 2.4 equiv) was added. The mixture was stirred at 80°C for 24 h. And then the mixture was purified by silica gel column chromatography (petroleum ether/ethyl acetate) to give the products.
68% at 20℃; for 1 h; Inert atmosphere A solution of 2-amino-4,6-dimethylpyridine (1.22 g, 10 mmol) in 10 mL of glacial acetic acid under N2 was treated with a solution of 1.6 g (10 mmol) Br2 in 2 mL of glacial acetic acid over 15 minutes with water bath cooling keeping the temperature below 20°C. The solution became a solid mass and was allowed to stand at r.t. for 1h. After cooling in an ice bath, the material was made alkaline with 20percent cold NaOH solution. Then the mixture was extracted with CH2Cl2 three times, the combined organic layer was dried over anhydrous Na2SO4, filtered and concentrated. The residue was purified on silica gel (Hexane-EtOAc, 2:1~1:1) to afford the product (1.37 g, 68percent) as a yellow solid.
68% at 20℃; for 1 h; Inert atmosphere A solution of 2-amino-4,6-dimethylpyridine (1.22 g, 10 mmol) in 10 mL of glacial acetic acid under N2 was treated with a solution of 1.6 g (10 mmol) Br2 in 2 mL of glacial acetic acid over 15 min with water bath cooling to keep the reaction temperature below 20 °C.
The solution became a solid mass and was allowed to stand at room temperature for 1 h.
After cooling in an ice bath, the material was made alkaline with 20percent cold NaOH solution.
Then the mixture was extracted with CH2Cl2 three times, the combined organic layer was dried over anhydrous Na2SO4, then filtered and concentrated.
The residue was purified on silica gel (Hexane-EtOAc, 2:1 to 1:1) to afford the product (1.37 g, 68percent) as a yellow solid.
Mp 143-144 °C. (lit.
[40]
143 °C).
1H NMR (CDCl3) 6.24 (s, 1H), 4.32 (br, 2H), 2.50 (s, 3H), 2.28 (s, 3H).
55% With sulfuric acid; bromine In water Step 1
Preparation of 2-amino-4,6-dimethyl-5-bromopyridine
20 g(0.164 mole) of 2-amino-4, 6-dimethylpyridine was added into a mixture of 69 ml of water and 16.1 g(0.164 mole) of sulfuric acid and the resulting solution was cooled to 0° C., and thereto was added 8.45 ml(0.164 mole) of bromine gradually at 0° C.
The resulting solution was stirred for 30 minutes, adjusted to pH 9 to 10 with aqueous sodium hydroxide solution and extracted with dichloromethane.
The organic layer was washed with water, dried over anhydrous Na2 SO4 and concentrated under reduced pressure.
The residue was purified with silica gel column chromatography to obtain 18.25 g of the title compound(yield 55percent) and 5.4 g of dibromo compound(yield 11.8percent).
48% With N-Bromosuccinimide In acetonitrile at 20℃; The mixture of 4,6-dimethylpyridin-2-amine (1 g, 8.2 mmol, 1.0 eq) and NBS (1.46 g, 8.2 mmol, 1.0 eq) in CH3CN (30 mL) was stirred at rt overnight. Then the mixture was concentrated, and the residue was purified on silica gel column (PE/EtOAc = 5/1) to afford 5-bromo-4,6-dimethylpyridin-2-amine as a yellow solid (800 mg, 48percent).

Reference: [1] Organic Process Research and Development, 2012, vol. 16, # 1, p. 109 - 116
[2] Patent: WO2011/103536, 2011, A1, . Location in patent: Page/Page column 43-44
[3] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 17, p. 5188 - 5201
[4] Pharmacy and Pharmacology Communications, 1999, vol. 5, # 3, p. 233 - 238
[5] Patent: WO2018/108671, 2018, A1, . Location in patent: Page/Page column 178; 179
[6] Tetrahedron Letters, 2014, vol. 55, # 36, p. 5058 - 5061
[7] Journal of Medicinal Chemistry, 2015, vol. 58, # 21, p. 8743 - 8749
[8] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 15, p. 5093 - 5097
[9] European Journal of Medicinal Chemistry, 2012, vol. 55, p. 395 - 408,14
[10] European Journal of Medicinal Chemistry, 2012, vol. 55, p. 395 - 408
[11] Journal of Organic Chemistry, 2004, vol. 69, # 26, p. 9215 - 9223
[12] Journal of Heterocyclic Chemistry, 2003, vol. 40, # 4, p. 569 - 573
[13] Patent: US5849753, 1998, A,
[14] Patent: WO2015/103317, 2015, A1, . Location in patent: Page/Page column 154
[15] Journal of the American Chemical Society, 1952, vol. 74, p. 1916,1918
  • 2
  • [ 128-08-5 ]
  • [ 5407-87-4 ]
  • [ 89856-44-0 ]
Reference: [1] Patent: US5693812, 1997, A,
  • 3
  • [ 5407-87-4 ]
  • [ 89856-44-0 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 1997, vol. 5, # 4, p. 673 - 678
[2] Bioorganic and Medicinal Chemistry, 1997, vol. 5, # 4, p. 673 - 678
  • 4
  • [ 99179-94-9 ]
  • [ 89856-44-0 ]
Reference: [1] Journal of the American Chemical Society, 1952, vol. 74, p. 1916,1918
  • 5
  • [ 5407-88-5 ]
  • [ 89856-44-0 ]
Reference: [1] Journal of the American Chemical Society, 1952, vol. 74, p. 1916,1918
  • 6
  • [ 89856-44-0 ]
  • [ 769-27-7 ]
Reference: [1] Patent: WO2015/103317, 2015, A1, . Location in patent: Page/Page column 154; 155
  • 7
  • [ 89856-44-0 ]
  • [ 5006-57-5 ]
YieldReaction ConditionsOperation in experiment
92%
Stage #1: With hydrogen bromide; sodium nitrite In water at 0 - 5℃; for 0.5 h;
Stage #2: With bromine In water at 5℃; for 0.5 h;
To a solution of 2-amino-5-bromo-4,6-dimethylpyridine (201 mg, 1 mmol) in HBr (48percent, 3 mL) at 0°C, was added dropwise a solution of NaNO2 (172 mg, 2.5 mmol) in H2O (0.6 mL). Then the mixture was stirred at 0~5°C for 30 minutes, Br2 (448 mg, 2.8 mmol) was added, keeping the temperature below 5°C. After a further 30 minutes, the mixture was made alkaline with 20percent cold NaOH solution. Then the mixture was extracted with EtOAc three times, the combined organic layer was dried over anhydrous Na2SO4, filtered and concentrated. The residue was purified on silica gel (Hexane-EtOAc, 10:1) to afford the product (243 mg, 92percent) as a pale yellow solid.
92% With hydrogen bromide; bromine; sodium nitrite In water at 0 - 5℃; for 1 h; To a solution of 1 (201 mg, 1 mmol) in HBr (48percent, 3 mL) at 0 °C, a solution of NaNO2 (172 mg, 2.5 mmol) in H2O (0.6 mL) was added dropwise.
Then the mixture was stirred at 0-5 °C for 30 min, Br2 (448 mg, 2.8 mmol) was added, while keeping the temperature below 5 °C.
After a further 30 min, the mixture was made alkaline with 20percent cold NaOH solution.
Then the mixture was extracted with EtOAc three times, the combined organic layer was dried over anhydrous Na2SO4, filtered and concentrated.
The residue was purified on silica gel (Hexane-EtOAc, 10:1) to afford the product (243 mg, 92percent) as a pale yellow solid.
Mp 62-63 °C. (lit.
[41]
63 °C).
1H NMR (CDCl3) δ 7.20 (s, 1H), 2.65 (s, 3H), 2.37 (s, 3H).
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 15, p. 5093 - 5097
[2] European Journal of Medicinal Chemistry, 2012, vol. 55, p. 395 - 408,14
[3] European Journal of Medicinal Chemistry, 2012, vol. 55, p. 395 - 408
  • 8
  • [ 89856-44-0 ]
  • [ 819069-57-3 ]
Reference: [1] Journal of Organic Chemistry, 2004, vol. 69, # 26, p. 9215 - 9223
[2] Patent: US2013/143907, 2013, A1,
[3] Patent: US2013/143907, 2013, A1,
[4] Patent: US2015/315198, 2015, A1,
[5] Patent: EP2982674, 2016, A1,
  • 9
  • [ 89856-44-0 ]
  • [ 918145-29-6 ]
YieldReaction ConditionsOperation in experiment
1.79 g
Stage #1: With hydrogenchloride; sodium nitrite In water at 0℃; for 0.166667 h;
Stage #2: With copper(l) chloride In water at 0 - 35℃; for 4.33333 h;
Preparation Example 21
Synthesis of 3-bromo-6-chloro-2,4-dimethylpyridine
5-bromo-4,6-dimethylpyridin-2-amine (CAS No. 89856-44-0; Aldrich) (4.00 g) was added to a mixed solution of concentrated hydrochloric acid (24 mL) and water (24 mL).
The solution was cooled to 0° C., and sodium nitrite (3.57 g) was added, followed by stirring at the same temperature for 10 minutes. Copper(I) chloride (5.91 g) was added to the solution, and the mixture was stirred at 0° C. for five minutes and at room temperature for four hours and 15 minutes.
The reaction mixture was cooled to 0° C., and a 5 N aqueous sodium hydroxide solution was added to make the reaction mixture basic.
Ethyl acetate was added to the reaction mixture, followed by filtration.
The organic layer in the filtrate was separated, and the aqueous layer was extracted with ethyl acetate.
The combined organic layers were concentrated under reduced pressure.
The residue was purified by silica gel column chromatography (ethyl acetate/n-heptane, 5percent) to give the title compound (1.79 g).
1H-NMR (400 MHz, CDCl3) δ (ppm): 2.39 (s, 3H), 2.65 (s, 3H), 7.06 (s, 1H).
Reference: [1] Organic Process Research and Development, 2012, vol. 16, # 1, p. 109 - 116
[2] Organic and Biomolecular Chemistry, 2010, vol. 8, # 21, p. 4815 - 4818
[3] Patent: WO2012/58187, 2012, A1, . Location in patent: Page/Page column 66; 67
[4] Patent: US2013/143907, 2013, A1, . Location in patent: Paragraph 0388; 0389; 0390
[5] Patent: WO2014/22528, 2014, A1, . Location in patent: Page/Page column 92
[6] Patent: WO2014/19186, 2014, A1, . Location in patent: Page/Page column 78
[7] Patent: WO2015/89809, 2015, A1, . Location in patent: Page/Page column 46
[8] Patent: WO2015/95256, 2015, A1, . Location in patent: Page/Page column 46
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 89856-44-0 ]

Bromides

Chemical Structure| 5407-86-3

[ 5407-86-3 ]

3,5-Dibromo-4,6-dimethylpyridin-2-amine

Similarity: 0.93

Chemical Structure| 42753-71-9

[ 42753-71-9 ]

2-Amino-5-bromo-6-methylpyridine

Similarity: 0.89

Chemical Structure| 89728-15-4

[ 89728-15-4 ]

5-Bromo-4,6-dimethylpyridine-2,3-diamine

Similarity: 0.84

Chemical Structure| 221135-63-3

[ 221135-63-3 ]

5-Bromo-3,6-dimethylpyridin-2-amine

Similarity: 0.83

Chemical Structure| 98198-48-2

[ 98198-48-2 ]

2-Amino-5-bromo-4-methylpyridine

Similarity: 0.83

Amines

Chemical Structure| 5407-86-3

[ 5407-86-3 ]

3,5-Dibromo-4,6-dimethylpyridin-2-amine

Similarity: 0.93

Chemical Structure| 42753-71-9

[ 42753-71-9 ]

2-Amino-5-bromo-6-methylpyridine

Similarity: 0.89

Chemical Structure| 89728-15-4

[ 89728-15-4 ]

5-Bromo-4,6-dimethylpyridine-2,3-diamine

Similarity: 0.84

Chemical Structure| 221135-63-3

[ 221135-63-3 ]

5-Bromo-3,6-dimethylpyridin-2-amine

Similarity: 0.83

Chemical Structure| 98198-48-2

[ 98198-48-2 ]

2-Amino-5-bromo-4-methylpyridine

Similarity: 0.83

Related Parent Nucleus of
[ 89856-44-0 ]

Pyridines

Chemical Structure| 5407-86-3

[ 5407-86-3 ]

3,5-Dibromo-4,6-dimethylpyridin-2-amine

Similarity: 0.93

Chemical Structure| 42753-71-9

[ 42753-71-9 ]

2-Amino-5-bromo-6-methylpyridine

Similarity: 0.89

Chemical Structure| 89728-15-4

[ 89728-15-4 ]

5-Bromo-4,6-dimethylpyridine-2,3-diamine

Similarity: 0.84

Chemical Structure| 221135-63-3

[ 221135-63-3 ]

5-Bromo-3,6-dimethylpyridin-2-amine

Similarity: 0.83

Chemical Structure| 98198-48-2

[ 98198-48-2 ]

2-Amino-5-bromo-4-methylpyridine

Similarity: 0.83